Kenya Bio-Vax Institute (KBVI) - BETA - 2024 |
|
|---|---|
|
State Department |
|
|
Programme |
|
|
Sub Programme |
|
|
Allocation: |
KES 281,500,000.00 (R) |
Key Performance Indicators
Key Output |
KPI |
Target Yr (2024) |
Target Yr (2025) |
Target Yr (2026) |
|---|---|---|---|---|
|
Vaccine Production Services |
Percentage completion rate of human vaccine fill-and-finish facility |
60 |
90 |
90 |
|
Vaccine Production Services |
No. of products manufactured |
- |
1 |
1 |
|
Vaccine Production Services |
Percentage completion rate of Research & Development centre |
10 |
20 |
20 |
|
Vaccine Production Services |
Number of HPTs technology transfer agreements |
1 |
1 |
1 |
|
Vaccine Production Services |
Number of personnel trained in administrative and specialized HPTs manufacturing |
50 |
70 |
70 |
|
Vaccine Production Services |
Number of specialty staff recruited |
20 |
20 |
20 |
|
Vaccine Production Services |
Percentage completion rate of quality management systems established |
75 |
95 |
95 |
|
Vaccine Production Services |
Number of partnerships and collaborations |
3 |
3 |
3 |
Previous Year Allocations
Num |
Year |
Recurrent |
Development |
Total |
|---|---|---|---|---|
|
1 |
KES 281,500,000.00 |
KES 0.00 |
KES 281,500,000.00 |
|
|
2 |
KES 150,000,000.00 |
KES 0.00 |
KES 150,000,000.00 |
Proportion of shared services on boarded onto the Digital Health Agency.: 25
KES 352,000,000.00
KES 180,000,000.00
(2024)
Number of Research evidence briefs developed: 17
KES 500,000,000.00
KES 400,000,000.00
(2024)
Number of New research protocols approved: 200
KES 2,508,950,000.00
(2024)